The outcomes of the analyses revealed that the expression of SLC7A5 was significantly increased in patients with breast cancer (Figures 4E, F), and the higher the expression of SLC7A5 was, the more advanced the tumor progression and the less differentiated the tumor cells (Figures 4G–P). Here, SLC7A5 is linked to neoplasm.